Renovo
Natural health product licensed in Canada
- Other names
- Renovo 14S30B
- Licence holder
- S.O.S. Pharma-Solution Inc.
- NPN or DIN-HM
- 80077105
- Status
- Active licence
- Licence date
- 2 May 2017
- Revision date
- 16 March 2019
- Form
- Capsule, libération-retardée
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lacticaseibacillus paracasei Source : BIO5452 | 2.4 Milliards d'UFC | Not calculated |
| Lacticaseibacillus paracasei Source : Lactobacillus paracasei - Cellule entière | 2.4 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : BIO5764 | 5.4 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : Bifidobacterium animalis subsp. lactis- Cellule entière | 5.4 Milliards d'UFC | Not calculated |
| Lactobacillus delbrueckii subsp. bulgaricus Source : Lactobacillus delbrueckii subsp. blugaricus- Whole | 0.03 Milliards d'UFC | Not calculated |
| Lactobacillus delbrueckii subsp. bulgaricus Source : BIO6744 | 0.03 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : BIO6307 | 2.4 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : Lactobacillus acidophilus - Cellule entière | 2.4 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : Bifidobacterium bifidum - Cellule entière | 0.6 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : BIO5480 | 0.6 Milliards d'UFC | Not calculated |
| Bifidobacterium breve Source : BIO6018 | 0.9 Milliards d'UFC | Not calculated |
| Bifidobacterium breve Source : Bifidobacterium breve - Cellule entière | 0.9 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. infantis Source : BIO5478 | 0.3 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. infantis Source : Bifidobacterium longum subsp. Infantis - Whole Cell | 0.3 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : BIO6283 | 0.3 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : Bifidobacterium longum subsp. longum - Cellule entière | 0.3 Milliards d'UFC | Not calculated |
| Lactobacillus casei Source : BIO5773 | 2.4 Milliards d'UFC | Not calculated |
| Lactobacillus casei Source : Lactobacillus casei- Cellule entière | 2.4 Milliards d'UFC | Not calculated |
| Lactobacillus gasseri Source : Lactobacillus gasseri- Cellule entière | 2.4 Milliards d'UFC | Not calculated |
| Lactobacillus gasseri Source : BIO6369 | 2.4 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : BIO1096 | 2.4 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : Lactobacillus plantarum - Cellule entière | 2.4 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : Lactobacillus rhamnosus - Cellule entière | 7.5 Milliards d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : BIO5326 | 7.5 Milliards d'UFC | Not calculated |
| Lactococcus lactis Source : BIO6722 | 2.4 Milliards d'UFC | Not calculated |
| Lactococcus lactis Source : Cellule entière | 2.4 Milliards d'UFC | Not calculated |
| Lactobacillus reuteri Source : Lactobacillus reuteri - cellule entière | 0.57 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Dioxyde de titane, Dioxyde de silicium, Acide ascorbique, Inuline, Eau purifiée, Gomme de gellane, bêta-D-glucane, Hypromellose, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps support intestinal/gastrointestinal health. Could promote a favorable gut flora.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment), do not use this product.
- Précautions et mises en garde
f you have nausea, fever, vomiting, bloody diarrhoea or severe abdominal pain, consult a health care practitioner prior to use. f symptoms of digestive upset (e.g. diarrhea) occur, worsen, or persist beyond 3 days, discontinue use and consult a health care practitioner.
Source
Official Health Canada record, licence 80077105
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2019. Photograph the packaging to check whether it has changed. Photograph the packaging